Access to Drug Treatments
This page has the latest updates about the impact of COVID-19 on access to drug treatments, clinical trials and regulatory authority timetables. For other information on research and drug treatments, please go here.
Some have asked whether patients due for nusinersen treatment should be tested for COVID-19 before they attend hospital. Expert clinicians advise that currently (as of 01/05/2020) they are not asking for patients to be tested, but if unwell (even if not COVID-19 positive) and even more so if COVID-19 positive, they would generally advise to postpone the administration of nusinersen. This may vary – talk with your treatment team if you’re not sure about what’s happening at your centre.